Xconomy National

Archives

by in

Entry	Author	Date	Location
The Missing Ingredient in Today’s Biotech: Guts	Luke Timmerman	07/11/11	National
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News	Luke Timmerman	04/28/11	Seattle
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO	Luke Timmerman	04/27/11	Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech	Luke Timmerman	11/09/10	Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move	Luke Timmerman	11/08/10	Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster	Luke Timmerman	10/26/10	Seattle
What Will Happen to ZymoGenetics’ Landmark Headquarters when Bristol Calls the Shots?	Luke Timmerman	09/13/10	Seattle
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three	Luke Timmerman	07/27/10	Seattle
Immune Design Nabs $32M for Targeted Vaccines	Luke Timmerman	07/26/10	Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	03/18/10	Seattle
A Brief Year-End Review of Seattle Biotech	Stewart Lyman	12/31/09	Seattle
Bezos Family Gives $10M to Hutch, Bruce Carter Back in the Saddle, Dendreon Deadline Set, & More Seattle-Area Life Sciences News	Luke Timmerman	11/25/09	Seattle
So Much For Gardening: Bruce Carter Joins Vaccine Startup Immune Design To Raise Cash	Luke Timmerman	11/23/09	Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO	Luke Timmerman	09/18/09	Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety	Luke Timmerman	08/20/09	Seattle
Johnson & Johnson, TB Alliance Form Partnership to Push New TB Drug Through Clinic	Luke Timmerman	06/17/09	Seattle
Life Sciences on a Budget: Startups Make Pitch for Angel Dollars at First Zino Society Forum	Luke Timmerman	02/25/09	Seattle
Hey, Don’t Forget the Puget Sound Life Sciences Universe!	Luke Timmerman	02/09/09	Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex	Luke Timmerman	01/05/09	Seattle
Seattle’s Top 10 Innovation Stories of the Half-Year (and Others We Just Plain Liked)	Gregory T. Huang	12/31/08	Seattle
Washington’s Life Sciences Ambassador, Jack Faris, Exits the Stage	Luke Timmerman	12/29/08	Seattle
3Tier Group Gets $10M, Socialmedian Sold for $7.5M, Gates Gives $7M to IDRI, & More Seattle-Area Deals News	Gregory T. Huang	12/23/08	Seattle
Amgen Tries to “Personalize” Drug, VLST Snags Deal, Tobacco Money Backs Research, & More Seattle-Area Life Sciences News	Luke Timmerman	12/18/08	Seattle
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity	Luke Timmerman	12/17/08	Seattle
Luck, Curiosity, Naivete: The Essential Ingredients of Innovation	Luke Timmerman	12/16/08	Seattle
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News	Luke Timmerman	12/04/08	Seattle
ZymoGenetics CEO Bruce Carter Retires, Promotes Doug Williams, Says Sad Goodbyes to Biotech “Family”	Luke Timmerman	11/21/08	Seattle
WBBA Hires Chris Rivera As President, Replacing Retiring Jack Faris	Luke Timmerman	11/19/08	Seattle
ZymoGenetics “Sleeper” for Hepatitis C Aims to Wipe Out Side Effects of Anti-Viral Therapy	Luke Timmerman	09/30/08	Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace	Luke Timmerman	08/06/08	Seattle
Page 1 of 2	next page »